New Ultrasound Technique Provides Clear Look at Hard- to-Diagnose Breast Cysts

Publication
Article
OncologyONCOLOGY Vol 15 No 9
Volume 15
Issue 9

A new ultrasound technique called breast harmonic imaging can be successfully used to diagnose hard-to-see breast cysts,

A new ultrasound technique called breast harmonic imaging can be successfully used to diagnose hard-to-see breast cysts, thus eliminating the need for some biopsies,according to a study presented at a recent American Roentgen Ray Society meetingheld in Seattle, Washington.

The study—which involved 30 patients with 117 breast cysts—found thatharmonic imaging provides higher resolution and better detail of small cysts orcysts that are deeper in the breast than can be detected by conventionalultrasound, said Derek Muradali, MD, of the University Health Network and MountSinai Hospital in Toronto, Canada.

Patients in the study underwent a conventional ultrasound examination and aharmonic imaging examination. Two radiologists reviewed the conventionalultrasound images and the harmonic images and found that the harmonic imageswere "superior to conventional ultrasound" in 80% of cases. Theradiologists did not know which images were conventional or harmonic when theymade their assessment.

Future Standard of Care?

"Harmonic imaging is now available on some ultrasound machines, and wesimply flip a switch on the machine to change to the harmonic image," saidDr. Muradali. Harmonic imaging has been used in the past, but it is onlyrecently that the linear transducers used in breast ultrasound have becomeavailable for use in harmonic imaging.

Harmonic imaging will likely become the standard of care for patients withcysts that are difficult to diagnose with conventional ultrasound, said Dr.Muradali. "In the past, we’ve been obliged to biopsy small cysts or thosedeep in the breast, because conventional ultrasound hasn’t provided the detailneeded to accurately diagnose them. Harmonic imaging provides us with the meansto avoid doing those biopsies." This saves the patient and the physiciantime, effort, and money, said Dr. Muradali.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.